NFKB1 and ovarian cancer: Moreover, silencing different IKK subunits or their pharmacological inhibition promote cell death and sensitize cancer cells to chemotherapeutic agents.29 Thus, we used the ovarian cancer cell line SKOV3, in which NF‐kB signaling has been shown to be upregulated,30 to test the effect of INH14 on the cell‐migration ability (wound‐healing assay).